LABORATORIOS FARSIMAN Trademark

Trademark Overview

On Tuesday, May 25, 2021, a trademark application was filed for LABORATORIOS FARSIMAN with the United States Patent and Trademark Office. The USPTO has given the LABORATORIOS FARSIMAN trademark a serial number of 90734392. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Friday, August 23, 2024. This trademark is owned by Laboratorios Farsiman, S.A.. The LABORATORIOS FARSIMAN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of pharmaceutical preparations and medicines
laboratorios farsiman

General Information

Serial Number90734392
Word MarkLABORATORIOS FARSIMAN
Filing DateTuesday, May 25, 2021
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateFriday, August 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 5, 2022

Trademark Statements

Translation of Words in MarkThe English translation of "LABORATORIOS" in the mark is "LABORATORIES".
NOT AVAILABLE"LABORATORIOS"
Goods and ServicesDevelopment of pharmaceutical preparations and medicines

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 20, 2021
Primary Code042
First Use Anywhere DateWednesday, December 1, 1999
First Use In Commerce DateWednesday, March 20, 2024

Trademark Owner History

Party NameLaboratorios Farsiman, S.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCholoma, Cortés
HN
Party NameLaboratorios Farsiman, S.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCholoma, Cortés
HN

Trademark Events

Event DateEvent Description
Friday, August 20, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 28, 2021NEW APPLICATION ENTERED
Saturday, February 19, 2022NON-FINAL ACTION E-MAILED
Saturday, February 5, 2022ASSIGNED TO EXAMINER
Saturday, February 19, 2022NON-FINAL ACTION WRITTEN
Saturday, February 19, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 4, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 4, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 5, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 19, 2022ASSIGNED TO EXAMINER
Monday, May 30, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 15, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 5, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 5, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 30, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, February 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 23, 2023SOU TEAS EXTENSION RECEIVED
Thursday, February 23, 2023SOU EXTENSION 1 FILED
Thursday, February 23, 2023SOU EXTENSION 1 GRANTED
Monday, July 31, 2023SOU TEAS EXTENSION RECEIVED
Thursday, February 29, 2024SOU EXTENSION 3 FILED
Wednesday, March 6, 2024TEAS PETITION TO REVIVE RECEIVED
Wednesday, March 6, 2024NOTICE OF REVIVAL - E-MAILED
Wednesday, March 6, 2024PETITION TO REVIVE-GRANTED
Wednesday, March 6, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, April 15, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 15, 2024SOU EXTENSION 3 GRANTED
Wednesday, August 21, 2024USE AMENDMENT FILED
Wednesday, August 21, 2024TEAS STATEMENT OF USE RECEIVED
Friday, August 23, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 31, 2023SOU EXTENSION 2 FILED
Monday, July 31, 2023SOU EXTENSION 2 GRANTED
Wednesday, August 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 6, 2024TEAS PETITION TO REVIVE RECEIVED
Wednesday, March 6, 2024NOTICE OF REVIVAL - E-MAILED

Related Keywords

farsiman laboratorios medicines preparations pharmaceutical development